Reports

Industry Research Reports

Long Read Sequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Long Read Sequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Service & Software

Published Date: 2026-02-16

Pages: 117 Pages

Report ld: 5998714

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Long Read Sequencing Market Size(US$)

den_QYR1
cagr

CAGR 2026-2032

8.7%

marketSize

Market Size,2032

USD 4,490

Million

Market Snapshot

Market Size in 2026 (Value)
US$ 2,722 million
Market Forecast in 2032(Value)
US$ 4,490 million
CAGR
8.7%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Long Read Sequencing was estimated to be worth US$ 2495 million in 2025 and is projected to reach US$ 4490 million, growing at a CAGR of 8.7% from 2026 to 2032.

Long Read Sequencing (LRS) represents a paradigm shift in genomics, moving from reconstructing the genome like a puzzle to reading it in near-contiguous pieces. Unlike Short Read Sequencing (SRS), which fragments DNA into pieces 150-300 base pairs long (requiring complex computational assembly), LRS reads single molecules in lengths of 10,000 to over 1,000,000 base pairs.

Market Drivers

1. Structural Variant (SV) Resolution (Clinical Driver)

Context: Short reads detect SNPs (single nucleotide variants) well. They miss 50-70% of structural variants (deletions, insertions, inversions, duplications >50bp).

Clinical Implication: SVs are implicated in autism, schizophrenia, epilepsy, cancer, and developmental disorders.

Driver: LRS detects SVs directly. No inference. The variant is seen in the read alignment.

Market Signal: Major medical centers (Mayo Clinic, Rady Children's, Broad) transitioning rare disease diagnostics to LRS.

2. Phasing & Haplotype Resolution (Mendelian Genetics)

The Problem: Humans are diploid. Short reads mix maternal and paternal alleles.

The Consequence: Cannot determine if two mutations are on the same chromosome (cis) or opposite (trans). Critical for recessive disease carrier status.

The Solution: Long reads span both variants. Native phasing.

Driver: Reproductive genetics. Carrier screening accuracy improvement.

This report provides a comprehensive view of the global market for Long Read Sequencing, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Long Read Sequencing market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Long Read Sequencing.

MARKET SEGMENTATION

By Company

  • Oxford Nanopore Technologies
  • Pacific Biosciences of California
  • BaseClear B.V.
  • Future Genomics Technologies
  • Garvan Institute of Medical Research
  • Genome Transcriptome Facility of Bordeaux
  • NextOmics
  • Takara Bio
  • Quantapore
  • Roche
  • MicrobesNG
  • Institute of Integrative Biology of the Cell

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Consumables
  • Instruments
  • Services

Segment by Application

  • Academic Research
  • Clinical Research
  • Hospitals & Clinics
  • Pharma & Biotech Entities
  • Other

Segment by Category

  • Human Genetics and Biomedicine
  • Microbiology and Infectious Disease
  • Plant and Animal Sciences
  • Functional Genomics and Transcriptomics
  • Population and Evolutionary Genomics

Segment by Division

  • PacBio (Single Molecule Real-Time; SMRT Sequencing)
  • Oxford Nanopore Technologies (ONT)
  • Emerging and Hybrid Technologies

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.

marn_i1

Chapter 2: Provides a detailed analysis of the Long Read Sequencing companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).

marn_i1

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

marn_i1

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

marn_i1

Chapter 5: Presents Long Read Sequencing revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

marn_i1

Chapter 6: Presents Long Read Sequencing revenue at the country level. It provides segmented data by Type and by Application for each country/region.

marn_i1

Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.

marn_i1

Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.

marn_i1

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Market Overview

1.1 Long Read Sequencing Product Introduction

1.2 Global Long Read Sequencing Market Size Forecast (2021–2032)

1.3 Long Read Sequencing Market Trends & Drivers

1.3.1 Long Read Sequencing Industry Trends

1.3.2 Long Read Sequencing Market Drivers & Opportunities

1.3.3 Long Read Sequencing Market Challenges

1.3.4 Long Read Sequencing Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Competitive Analysis by Company

2.1 Global Long Read Sequencing Players Revenue Ranking (2025)

2.2 Global Long Read Sequencing Revenue by Company (2021–2026)

2.3 Key Companies’ R&D and Operations Footprint and Headquarters

2.4 Key Companies Long Read Sequencing Product Offerings

2.5 Key Companies General Availability (GA) Timeline for Long Read Sequencing

2.6 Long Read Sequencing Market Competitive Analysis

2.6.1 Long Read Sequencing Market Concentration Rate (2021–2026)

2.6.2 Top 5 and Top 10 Global Companies by Long Read Sequencing Revenue in 2025

2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Long Read Sequencing revenue, 2025

2.7 Mergers & Acquisitions and Expansion

muLu

3 Segmentation Long Read Sequencing Market Classification

3.1 Introduction by Type

3.1.1 Consumables

3.1.2 Instruments

3.1.3 Services

3.1.4 Global Long Read Sequencing Sales Value by Type

3.1.4.1 Global Long Read Sequencing Sales Value by Type (2021 vs 2025 vs 2032)

3.1.4.2 Global Long Read Sequencing Sales Value, by Type (2021–2032)

3.1.4.3 Global Long Read Sequencing Sales Value, by Type (%), 2021–2032

3.2 Introduction by Industry

3.2.1 Human Genetics and Biomedicine

3.2.2 Microbiology and Infectious Disease

3.2.3 Plant and Animal Sciences

3.2.4 Functional Genomics and Transcriptomics

3.2.5 Population and Evolutionary Genomics

3.2.6 Global Long Read Sequencing Sales Value by Industry

3.2.6.1 Global Long Read Sequencing Sales Value by Industry (2021 vs 2025 vs 2032)

3.2.6.2 Global Long Read Sequencing Sales Value, by Industry (2021–2032)

3.2.6.3 Global Long Read Sequencing Sales Value, by Industry (%), 2021–2032

3.3 Introduction by Technology

3.3.1 PacBio (Single Molecule Real-Time; SMRT Sequencing)

3.3.2 Oxford Nanopore Technologies (ONT)

3.3.3 Emerging and Hybrid Technologies

3.3.4 Global Long Read Sequencing Sales Value by Technology

3.3.4.1 Global Long Read Sequencing Sales Value by Technology (2021 vs 2025 vs 2032)

3.3.4.2 Global Long Read Sequencing Sales Value, by Technology (2021–2032)

3.3.4.3 Global Long Read Sequencing Sales Value, by Technology (%), 2021–2032

muLu

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Academic Research

4.1.2 Clinical Research

4.1.3 Hospitals & Clinics

4.1.4 Pharma & Biotech Entities

4.1.5 Other

4.2 Global Long Read Sequencing Sales Value by Application

4.2.1 Global Long Read Sequencing Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Long Read Sequencing Sales Value by Application (2021–2032)

4.2.3 Global Long Read Sequencing Sales Value by Application (%), 2021–2032

muLu

5 Segmentation by Region

5.1 Global Long Read Sequencing Sales Value by Region

5.1.1 Global Long Read Sequencing Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Long Read Sequencing Sales Value by Region (2021–2026)

5.1.3 Global Long Read Sequencing Sales Value by Region (2027–2032)

5.1.4 Global Long Read Sequencing Sales Value by Region (%), 2021–2032

5.2 North America

5.2.1 North America Long Read Sequencing Sales Value, 2021–2032

5.2.2 North America Long Read Sequencing Sales Value by Country (%), 2025 vs 2032

5.3 Europe

5.3.1 Europe Long Read Sequencing Sales Value, 2021–2032

5.3.2 Europe Long Read Sequencing Sales Value by Country (%), 2025 vs 2032

5.4 Asia Pacific

5.4.1 Asia Pacific Long Read Sequencing Sales Value, 2021–2032

5.4.2 Asia Pacific Long Read Sequencing Sales Value by Subregion (%), 2025 vs 2032

5.5 South America

5.5.1 South America Long Read Sequencing Sales Value, 2021–2032

5.5.2 South America Long Read Sequencing Sales Value by Country (%), 2025 vs 2032

5.6 Middle East & Africa

5.6.1 Middle East & Africa Long Read Sequencing Sales Value, 2021–2032

5.6.2 Middle East & Africa Long Read Sequencing Sales Value by Country (%), 2025 vs 2032

muLu

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Long Read Sequencing Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Long Read Sequencing Sales Value, 2021–2032

6.3 United States

6.3.1 United States Long Read Sequencing Sales Value, 2021–2032

6.3.2 United States Long Read Sequencing Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Long Read Sequencing Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Long Read Sequencing Sales Value, 2021–2032

6.4.2 Europe Long Read Sequencing Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Long Read Sequencing Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Long Read Sequencing Sales Value, 2021–2032

6.5.2 China Long Read Sequencing Sales Value by Type (%), 2025 vs 2032

6.5.3 China Long Read Sequencing Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Long Read Sequencing Sales Value, 2021–2032

6.6.2 Japan Long Read Sequencing Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Long Read Sequencing Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Long Read Sequencing Sales Value, 2021–2032

6.7.2 South Korea Long Read Sequencing Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Long Read Sequencing Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Long Read Sequencing Sales Value, 2021–2032

6.8.2 Southeast Asia Long Read Sequencing Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Long Read Sequencing Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Long Read Sequencing Sales Value, 2021–2032

6.9.2 India Long Read Sequencing Sales Value by Type (%), 2025 vs 2032

6.9.3 India Long Read Sequencing Sales Value by Application, 2025 vs 2032

muLu

7 Company Profiles

7.1 Oxford Nanopore Technologies

7.1.1 Oxford Nanopore Technologies Profile

7.1.2 Oxford Nanopore Technologies Main Business

7.1.3 Oxford Nanopore Technologies Long Read Sequencing Products, Services, and Solutions

7.1.4 Oxford Nanopore Technologies Long Read Sequencing Revenue (US$ Million), 2021–2026

7.1.5 Oxford Nanopore Technologies Recent Developments

7.2 Pacific Biosciences of California

7.2.1 Pacific Biosciences of California Profile

7.2.2 Pacific Biosciences of California Main Business

7.2.3 Pacific Biosciences of California Long Read Sequencing Products, Services, and Solutions

7.2.4 Pacific Biosciences of California Long Read Sequencing Revenue (US$ Million), 2021–2026

7.2.5 Pacific Biosciences of California Recent Developments

7.3 BaseClear B.V.

7.3.1 BaseClear B.V. Profile

7.3.2 BaseClear B.V. Main Business

7.3.3 BaseClear B.V. Long Read Sequencing Products, Services, and Solutions

7.3.4 BaseClear B.V. Long Read Sequencing Revenue (US$ Million), 2021–2026

7.3.5 BaseClear B.V. Recent Developments

7.4 Future Genomics Technologies

7.4.1 Future Genomics Technologies Profile

7.4.2 Future Genomics Technologies Main Business

7.4.3 Future Genomics Technologies Long Read Sequencing Products, Services, and Solutions

7.4.4 Future Genomics Technologies Long Read Sequencing Revenue (US$ Million), 2021–2026

7.4.5 Future Genomics Technologies Recent Developments

7.5 Garvan Institute of Medical Research

7.5.1 Garvan Institute of Medical Research Profile

7.5.2 Garvan Institute of Medical Research Main Business

7.5.3 Garvan Institute of Medical Research Long Read Sequencing Products, Services, and Solutions

7.5.4 Garvan Institute of Medical Research Long Read Sequencing Revenue (US$ Million), 2021–2026

7.5.5 Garvan Institute of Medical Research Recent Developments

7.6 Genome Transcriptome Facility of Bordeaux

7.6.1 Genome Transcriptome Facility of Bordeaux Profile

7.6.2 Genome Transcriptome Facility of Bordeaux Main Business

7.6.3 Genome Transcriptome Facility of Bordeaux Long Read Sequencing Products, Services, and Solutions

7.6.4 Genome Transcriptome Facility of Bordeaux Long Read Sequencing Revenue (US$ Million), 2021–2026

7.6.5 Genome Transcriptome Facility of Bordeaux Recent Developments

7.7 NextOmics

7.7.1 NextOmics Profile

7.7.2 NextOmics Main Business

7.7.3 NextOmics Long Read Sequencing Products, Services, and Solutions

7.7.4 NextOmics Long Read Sequencing Revenue (US$ Million), 2021–2026

7.7.5 NextOmics Recent Developments

7.8 Takara Bio

7.8.1 Takara Bio Profile

7.8.2 Takara Bio Main Business

7.8.3 Takara Bio Long Read Sequencing Products, Services, and Solutions

7.8.4 Takara Bio Long Read Sequencing Revenue (US$ Million), 2021–2026

7.8.5 Takara Bio Recent Developments

7.9 Quantapore

7.9.1 Quantapore Profile

7.9.2 Quantapore Main Business

7.9.3 Quantapore Long Read Sequencing Products, Services, and Solutions

7.9.4 Quantapore Long Read Sequencing Revenue (US$ Million), 2021–2026

7.9.5 Quantapore Recent Developments

7.10 Roche

7.10.1 Roche Profile

7.10.2 Roche Main Business

7.10.3 Roche Long Read Sequencing Products, Services, and Solutions

7.10.4 Roche Long Read Sequencing Revenue (US$ Million), 2021–2026

7.10.5 Roche Recent Developments

7.11 MicrobesNG

7.11.1 MicrobesNG Profile

7.11.2 MicrobesNG Main Business

7.11.3 MicrobesNG Long Read Sequencing Products, Services, and Solutions

7.11.4 MicrobesNG Long Read Sequencing Revenue (US$ Million), 2021–2026

7.11.5 MicrobesNG Recent Developments

7.12 Institute of Integrative Biology of the Cell

7.12.1 Institute of Integrative Biology of the Cell Profile

7.12.2 Institute of Integrative Biology of the Cell Main Business

7.12.3 Institute of Integrative Biology of the Cell Long Read Sequencing Products, Services, and Solutions

7.12.4 Institute of Integrative Biology of the Cell Long Read Sequencing Revenue (US$ Million), 2021–2026

7.12.5 Institute of Integrative Biology of the Cell Recent Developments

muLu

8 Industry Chain Analysis

8.1 Long Read Sequencing Value Chain

8.2 Long Read Sequencing Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Cost Structure

8.3 Midstream Analysis

8.4 Downstream (Customer) Analysis

8.5 Sales Model and Sales Channelss

8.5.1 Long Read Sequencing Sales Model

8.5.2 Sales Channels

8.5.3 Long Read Sequencing Distributors

muLu

9 Research Findings and Conclusion

muLu

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Long Read Sequencing Market Trends
Table 2. Long Read Sequencing Market Drivers & Opportunities
Table 3. Long Read Sequencing Market Challenges
Table 4. Long Read Sequencing Market Restraints
Table 5. Global Long Read Sequencing Revenue by Company (US$ Million), 2021–2026
Table 6. Global Long Read Sequencing Revenue Market Share by Company (2021–2026)
Table 7. Key Companies’ R&D and Operations Footprint and Headquarters
Table 8. Key Companies Long Read Sequencing Product Type
Table 9. Key Companies General Availability (GA) Timeline for Long Read Sequencing
Table 10. Global Long Read Sequencing Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Long Read Sequencing revenue, 2025
Table 12. Mergers & Acquisitions and Expansion Plans
Table 13. Global Long Read Sequencing Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 14. Global Long Read Sequencing Sales Value by Type (US$ Million), 2021–2026
Table 15. Global Long Read Sequencing Sales Value by Type (US$ Million), 2027–2032
Table 16. Global Long Read Sequencing Sales Market Share in Value by Type (2021–2026)
Table 17. Global Long Read Sequencing Sales Market Share in Value by Type (2027–2032)
Table 18. Global Long Read Sequencing Sales Value by Industry: 2021 vs 2025 vs 2032 (US$ Million)
Table 19. Global Long Read Sequencing Sales Value by Industry (US$ Million), 2021–2026
Table 20. Global Long Read Sequencing Sales Value by Industry (US$ Million), 2027–2032
Table 21. Global Long Read Sequencing Sales Market Share in Value by Industry (2021–2026)
Table 22. Global Long Read Sequencing Sales Market Share in Value by Industry (2027–2032)
Table 23. Global Long Read Sequencing Sales Value by Technology: 2021 vs 2025 vs 2032 (US$ Million)
Table 24. Global Long Read Sequencing Sales Value by Technology (US$ Million), 2021–2026
Table 25. Global Long Read Sequencing Sales Value by Technology (US$ Million), 2027–2032
Table 26. Global Long Read Sequencing Sales Market Share in Value by Technology (2021–2026)
Table 27. Global Long Read Sequencing Sales Market Share in Value by Technology (2027–2032)
Table 28. Global Long Read Sequencing Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. Global Long Read Sequencing Sales Value by Application (US$ Million), 2021–2026
Table 30. Global Long Read Sequencing Sales Value by Application (US$ Million), 2027–2032
Table 31. Global Long Read Sequencing Sales Market Share in Value by Application (2021–2026)
Table 32. Global Long Read Sequencing Sales Market Share in Value by Application (2027–2032)
Table 33. Global Long Read Sequencing Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 34. Global Long Read Sequencing Sales Value by Region (US$ Million), 2021–2026
Table 35. Global Long Read Sequencing Sales Value by Region (US$ Million), 2027–2032
Table 36. Global Long Read Sequencing Sales Value by Region (%), 2021–2026
Table 37. Global Long Read Sequencing Sales Value by Region (%), 2027–2032
Table 38. Key Countries/Regions Long Read Sequencing Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 39. Key Countries/Regions Long Read Sequencing Sales Value, (US$ Million), 2021–2026
Table 40. Key Countries/Regions Long Read Sequencing Sales Value, (US$ Million), 2027–2032
Table 41. Oxford Nanopore Technologies Basic Information List
Table 42. Oxford Nanopore Technologies Description and Business Overview
Table 43. Oxford Nanopore Technologies Long Read Sequencing Products, Services, and Solutions
Table 44. Revenue (US$ Million) in Long Read Sequencing Business of Oxford Nanopore Technologies (2021–2026)
Table 45. Oxford Nanopore Technologies Recent Developments
Table 46. Pacific Biosciences of California Basic Information List
Table 47. Pacific Biosciences of California Description and Business Overview
Table 48. Pacific Biosciences of California Long Read Sequencing Products, Services, and Solutions
Table 49. Revenue (US$ Million) in Long Read Sequencing Business of Pacific Biosciences of California (2021–2026)
Table 50. Pacific Biosciences of California Recent Developments
Table 51. BaseClear B.V. Basic Information List
Table 52. BaseClear B.V. Description and Business Overview
Table 53. BaseClear B.V. Long Read Sequencing Products, Services, and Solutions
Table 54. Revenue (US$ Million) in Long Read Sequencing Business of BaseClear B.V. (2021–2026)
Table 55. BaseClear B.V. Recent Developments
Table 56. Future Genomics Technologies Basic Information List
Table 57. Future Genomics Technologies Description and Business Overview
Table 58. Future Genomics Technologies Long Read Sequencing Products, Services, and Solutions
Table 59. Revenue (US$ Million) in Long Read Sequencing Business of Future Genomics Technologies (2021–2026)
Table 60. Future Genomics Technologies Recent Developments
Table 61. Garvan Institute of Medical Research Basic Information List
Table 62. Garvan Institute of Medical Research Description and Business Overview
Table 63. Garvan Institute of Medical Research Long Read Sequencing Products, Services, and Solutions
Table 64. Revenue (US$ Million) in Long Read Sequencing Business of Garvan Institute of Medical Research (2021–2026)
Table 65. Garvan Institute of Medical Research Recent Developments
Table 66. Genome Transcriptome Facility of Bordeaux Basic Information List
Table 67. Genome Transcriptome Facility of Bordeaux Description and Business Overview
Table 68. Genome Transcriptome Facility of Bordeaux Long Read Sequencing Products, Services, and Solutions
Table 69. Revenue (US$ Million) in Long Read Sequencing Business of Genome Transcriptome Facility of Bordeaux (2021–2026)
Table 70. Genome Transcriptome Facility of Bordeaux Recent Developments
Table 71. NextOmics Basic Information List
Table 72. NextOmics Description and Business Overview
Table 73. NextOmics Long Read Sequencing Products, Services, and Solutions
Table 74. Revenue (US$ Million) in Long Read Sequencing Business of NextOmics (2021–2026)
Table 75. NextOmics Recent Developments
Table 76. Takara Bio Basic Information List
Table 77. Takara Bio Description and Business Overview
Table 78. Takara Bio Long Read Sequencing Products, Services, and Solutions
Table 79. Revenue (US$ Million) in Long Read Sequencing Business of Takara Bio (2021–2026)
Table 80. Takara Bio Recent Developments
Table 81. Quantapore Basic Information List
Table 82. Quantapore Description and Business Overview
Table 83. Quantapore Long Read Sequencing Products, Services, and Solutions
Table 84. Revenue (US$ Million) in Long Read Sequencing Business of Quantapore (2021–2026)
Table 85. Quantapore Recent Developments
Table 86. Roche Basic Information List
Table 87. Roche Description and Business Overview
Table 88. Roche Long Read Sequencing Products, Services, and Solutions
Table 89. Revenue (US$ Million) in Long Read Sequencing Business of Roche (2021–2026)
Table 90. Roche Recent Developments
Table 91. MicrobesNG Basic Information List
Table 92. MicrobesNG Description and Business Overview
Table 93. MicrobesNG Long Read Sequencing Products, Services, and Solutions
Table 94. Revenue (US$ Million) in Long Read Sequencing Business of MicrobesNG (2021–2026)
Table 95. MicrobesNG Recent Developments
Table 96. Institute of Integrative Biology of the Cell Basic Information List
Table 97. Institute of Integrative Biology of the Cell Description and Business Overview
Table 98. Institute of Integrative Biology of the Cell Long Read Sequencing Products, Services, and Solutions
Table 99. Revenue (US$ Million) in Long Read Sequencing Business of Institute of Integrative Biology of the Cell (2021–2026)
Table 100. Institute of Integrative Biology of the Cell Recent Developments
Table 101. Revenue (US$ Million) in Long Read Sequencing Business of Company 40 (2021–2026)
Table 102. Company 40 Recent Developments
Table 103. Key Raw Materials Lists
Table 104. Key Suppliers of Raw Materials Lists
Table 105. Long Read Sequencing Downstream Customers
Table 106. Long Read Sequencing Distributors List
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Long Read Sequencing Product Picture
Figure 2. Global Long Read Sequencing Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Long Read Sequencing Sales Value (US$ Million), 2021–2032
Figure 4. Long Read Sequencing Report Years Considered
Figure 5. Global Long Read Sequencing Players Revenue Ranking (US$ Million), 2025
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Long Read Sequencing Revenue in 2025
Figure 7. Long Read Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 8. Consumables Picture
Figure 9. Instruments Picture
Figure 10. Services Picture
Figure 11. Global Long Read Sequencing Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Long Read Sequencing Sales Value Market Share by Type, 2025 & 2032
Figure 13. Human Genetics and Biomedicine Picture
Figure 14. Microbiology and Infectious Disease Picture
Figure 15. Plant and Animal Sciences Picture
Figure 16. Functional Genomics and Transcriptomics Picture
Figure 17. Population and Evolutionary Genomics Picture
Figure 18. Global Long Read Sequencing Sales Value by Industry (US$ Million), 2021 vs 2025 vs 2032
Figure 19. Global Long Read Sequencing Sales Value Market Share by Industry, 2025 & 2032
Figure 20. PacBio (Single Molecule Real-Time; SMRT Sequencing) Picture
Figure 21. Oxford Nanopore Technologies (ONT) Picture
Figure 22. Emerging and Hybrid Technologies Picture
Figure 23. Global Long Read Sequencing Sales Value by Technology (US$ Million), 2021 vs 2025 vs 2032
Figure 24. Global Long Read Sequencing Sales Value Market Share by Technology, 2025 & 2032
Figure 25. Product Picture of Academic Research
Figure 26. Product Picture of Clinical Research
Figure 27. Product Picture of Hospitals & Clinics
Figure 28. Product Picture of Pharma & Biotech Entities
Figure 29. Product Picture of Other
Figure 30. Global Long Read Sequencing Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 31. Global Long Read Sequencing Sales Value Market Share by Application, 2025 & 2032
Figure 32. North America Long Read Sequencing Sales Value (US$ Million), 2021–2032
Figure 33. North America Long Read Sequencing Sales Value by Country (%), 2025 vs 2032
Figure 34. Europe Long Read Sequencing Sales Value (US$ Million), 2021–2032
Figure 35. Europe Long Read Sequencing Sales Value by Country (%), 2025 vs 2032
Figure 36. Asia Pacific Long Read Sequencing Sales Value (US$ Million), 2021–2032
Figure 37. Asia Pacific Long Read Sequencing Sales Value by Subregion (%), 2025 vs 2032
Figure 38. South America Long Read Sequencing Sales Value (US$ Million), 2021–2032
Figure 39. South America Long Read Sequencing Sales Value by Country (%), 2025 vs 2032
Figure 40. Middle East & Africa Long Read Sequencing Sales Value (US$ Million), 2021–2032
Figure 41. Middle East & Africa Long Read Sequencing Sales Value by Country (%), 2025 vs 2032
Figure 42. Key Countries/Regions Long Read Sequencing Sales Value (%), 2021–2032
Figure 43. United States Long Read Sequencing Sales Value (US$ Million), 2021–2032
Figure 44. United States Long Read Sequencing Sales Value by Type (%), 2025 vs 2032
Figure 45. United States Long Read Sequencing Sales Value by Application (%), 2025 vs 2032
Figure 46. Europe Long Read Sequencing Sales Value (US$ Million), 2021–2032
Figure 47. Europe Long Read Sequencing Sales Value by Type (%), 2025 vs 2032
Figure 48. Europe Long Read Sequencing Sales Value by Application (%), 2025 vs 2032
Figure 49. China Long Read Sequencing Sales Value (US$ Million), 2021–2032
Figure 50. China Long Read Sequencing Sales Value by Type (%), 2025 vs 2032
Figure 51. China Long Read Sequencing Sales Value by Application (%), 2025 vs 2032
Figure 52. Japan Long Read Sequencing Sales Value (US$ Million), 2021–2032
Figure 53. Japan Long Read Sequencing Sales Value by Type (%), 2025 vs 2032
Figure 54. Japan Long Read Sequencing Sales Value by Application (%), 2025 vs 2032
Figure 55. South Korea Long Read Sequencing Sales Value (US$ Million), 2021–2032
Figure 56. South Korea Long Read Sequencing Sales Value by Type (%), 2025 vs 2032
Figure 57. South Korea Long Read Sequencing Sales Value by Application (%), 2025 vs 2032
Figure 58. Southeast Asia Long Read Sequencing Sales Value (US$ Million), 2021–2032
Figure 59. Southeast Asia Long Read Sequencing Sales Value by Type (%), 2025 vs 2032
Figure 60. Southeast Asia Long Read Sequencing Sales Value by Application (%), 2025 vs 2032
Figure 61. India Long Read Sequencing Sales Value (US$ Million), 2021–2032
Figure 62. India Long Read Sequencing Sales Value by Type (%), 2025 vs 2032
Figure 63. India Long Read Sequencing Sales Value by Application (%), 2025 vs 2032
Figure 64. Long Read Sequencing Value Chain
Figure 65. Long Read Sequencing Cost Structure
Figure 66. Channels of Distribution (Direct Sales, and Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Long Read Sequencing market?zhanKai
The top companies in the global Long Read Sequencing market are Oxford Nanopore Technologies、Pacific Biosciences of California、BaseClear B.V..
What is the annual compound growth rate of the global Long Read Sequencing market size from 2026 to 2032?shouQi
Which region is expected to have the highest market share?shouQi
What was the global market size of Long Read Sequencing in 2026?shouQi
What was the global market size of Long Read Sequencing in 2032?shouQi
den_biaoTiZhungShi

Related Reports

Long Read Sequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Service & Software

Published Date: 2026-02-16

Pages: 117 Pages

Report ld: 5998714

CHOOSE LICENSE TYPE
tip

USD 3950.00

tip

USD 5925.00

tip

USD 7900.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Offline

HITESH

English, Hindi

Online

TANG XIN

Japanese,English

Online

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Online

YUJIE TIAN

Chinese, English

Online

DAMON

Chinese, English

Online

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now